Jump to content

Nanobacterium: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
merge dupe refs, fixes volume number error
Line 13: Line 13:
A paper published in 2000 by a team led by an [[NIH]] scientist [[John Cisar]] further tested these ideas. It stated that what had previously been described as "self-replication" was a form of [[Crystal structure|crystalline]] growth. The only DNA detected in his specimens was identified as coming from the bacteria ''Phyllobacterium mysinacearum'', which is a common contaminant in PCR reactions.<ref name=Cisar >{{cite journal |author=Cisar J, Xu D, Thompson J, Swaim W, Hu L, Kopecko D |title=An alternative interpretation of nanobacteria-induced biomineralization |url=http://www.pnas.org/cgi/content/full/97/21/11511 |journal=Proc Natl Acad Sci USA |volume=97 |issue=21 |pages=11511–5 |year=2000 |pmid=11027350 |doi=10.1073/pnas.97.21.11511 |pmc=17231 |bibcode=2000PNAS...9711511C}}</ref>
A paper published in 2000 by a team led by an [[NIH]] scientist [[John Cisar]] further tested these ideas. It stated that what had previously been described as "self-replication" was a form of [[Crystal structure|crystalline]] growth. The only DNA detected in his specimens was identified as coming from the bacteria ''Phyllobacterium mysinacearum'', which is a common contaminant in PCR reactions.<ref name=Cisar >{{cite journal |author=Cisar J, Xu D, Thompson J, Swaim W, Hu L, Kopecko D |title=An alternative interpretation of nanobacteria-induced biomineralization |url=http://www.pnas.org/cgi/content/full/97/21/11511 |journal=Proc Natl Acad Sci USA |volume=97 |issue=21 |pages=11511–5 |year=2000 |pmid=11027350 |doi=10.1073/pnas.97.21.11511 |pmc=17231 |bibcode=2000PNAS...9711511C}}</ref>


Kajander and Ciftcioglu set up a company in Finland in 2000, Nanobac Oy, to market medical diagnostic kits for identifying nanobacteria to medical researchers, and develop prescription medical treatments for calcification-associated diseases. The company was absorbed in 2003 by Nanobac Pharmaceuticals, Inc., a publicly traded company in Tampa, Florida founded by nanobiotic developer Gary Mezo.
Kajander and Ciftcioglu set up a company in Finland in 2000, Nanobac Oy, to market medical diagnostic kits for identifying nanobacteria to medical researchers. Kajander & Ciftcioglu's Nanobac OY was purchased in 2003 by Nanobac Pharmaceuticals, Inc., a publicly traded company in Tampa, Florida founded by nanobiotic developer Gary S. Mezo. Mezo developed the nanobiotics '''NanobacTX, Urobac and Dermabac''' and currently makes them available exclusively through his privately-held company, '''NanoBiotech Pharma. http://www.nanobiotech.us'''


==2001–present==
==2001–present==

Revision as of 20:25, 16 December 2011

Structures found on meteorite fragment Allan Hills 84001

Nanobacterium (pl. nanobacteria) is the unit or member name of a proposed class of living organisms, specifically cell-walled microorganisms with a size much smaller than the generally accepted lower limit size for life (about 200 nanometres for bacteria). Originally based on observed nano-scale structures in geological formations (including one meteorite), the status of nanobacteria is controversial, with some researchers suggesting they are a new class of living organisms[1][2] capable of incorporating radiolabeled uridine,[3] and others attributing to them a simpler, abiotic nature.[4][5] One skeptic dubbed them "the cold fusion of microbiology", in reference to a notorious episode of erroneous science.[6]

The term "calcifying nanoparticles" (CNPs) has also been used as a conservative name regarding their possible status as a life form. The most recent research tends to agree that these structures exist, and probably replicate in some way.[7] Their status as living entities is still debated,[citation needed] though some researchers claim that the case that they are nonliving crystalline particles is conclusively proven.[8] In medicine, they have been implicated in the formation of both kidney stones and arterial plaque.

1981–2000

In 1981 Torella and Morita described very small cells called ultramicrobacteria. Defined as being smaller than 300 nm, by 1982 MacDonell and Hood found that some could pass through a 200 nm membrane. Early in 1989, geologist Robert L. Folk found what he later identified as nannobacteria (written with double "n"), that is, nanoparticles isolated from geological specimens[9] in travertine from hot springs of Viterbo, Italy. Initially searching for a bacterial cause for travertine deposition, scanning electron microscope examination of the mineral where no bacteria were detectable revealed extremely small objects which appeared to be biological. His first oral presentation elicited what he called "mostly a stony silence", at the 1992 Geological Society of America's annual convention.[10] He proposed that nanobacteria are the principal agents of precipitation of all minerals and crystals on Earth formed in liquid water, that they also cause all oxidation of metals, and that they are abundant in many biological specimens.[10]

In 1996, NASA scientist David McKay published a study suggesting the existence of nanofossils — fossils of Martian nanobacteria — in ALH84001, a meteorite originating from Mars and found in Antarctica.[11]

Nanobacterium sanguineum was proposed in 1998 as an explanation of certain kinds of pathologic calcification (apatite in kidney stones) by Finnish researcher Olavi Kajander and Turkish researcher Neva Ciftcioglu, working at the University of Kuopio in Finland. According to the researchers the particles self-replicated in microbiological culture, and the researchers further reported having identified DNA in these structures by staining.[12]

A paper published in 2000 by a team led by an NIH scientist John Cisar further tested these ideas. It stated that what had previously been described as "self-replication" was a form of crystalline growth. The only DNA detected in his specimens was identified as coming from the bacteria Phyllobacterium mysinacearum, which is a common contaminant in PCR reactions.[4]

Kajander and Ciftcioglu set up a company in Finland in 2000, Nanobac Oy, to market medical diagnostic kits for identifying nanobacteria to medical researchers. Kajander & Ciftcioglu's Nanobac OY was purchased in 2003 by Nanobac Pharmaceuticals, Inc., a publicly traded company in Tampa, Florida founded by nanobiotic developer Gary S. Mezo. Mezo developed the nanobiotics NanobacTX, Urobac and Dermabac and currently makes them available exclusively through his privately-held company, NanoBiotech Pharma. http://www.nanobiotech.us

2001–present

In 2004 a Mayo Clinic team led by Franklin Cockerill, John Lieske, and Virginia M. Miller, reported to have isolated nanobacteria from diseased human arteries and kidney stones. Their results were published in 2004 and 2006 respectively.[3][13] Similar findings were obtained in 2005 by László Puskás at the DNA Lab, University of Szeged, Hungary. Dr. Puskás identified these particles in cultures obtained from human atherosclerotic aortic walls and blood samples of atherosclerotic patients but the group was unable to detect DNA in these samples.[14]

In 2005, Ciftcioglu and her research team at NASA used a rotating cell culture flask, which simulates some aspects of low-gravity conditions, to culture nanobacteria suspected of rapidly forming kidney stones in astronauts. In this environment, they were found to multiply five times faster than in normal Earth gravity. The study concluded that nanobacteria might have a potential role in forming kidney stones and may need to be screened for in crews pre-flight.[15]

The February 2008 PLoS Pathogens article focused on the comprehensive characterization of nanobacteria. The authors say that their results rule out the existence of nanobacteria as living entities and that they are instead a unique self-propagating entity, namely self-propagating mineral-fetuin complexes.[16]

An April 2008 PNAS article also reported that blood nanobacteria are not living organisms and stated that "CaCO3 precipitates prepared in vitro are remarkably similar to purported nanobacteria in terms of their uniformly sized, membrane-delineated vesicular shapes, with cellular division-like formations and aggregations in the form of colonies."[5] The growth of such "biomorphic" inorganic precipitates was studied in detail in a 2009 Science paper, which showed that unusual crystal growth mechanisms can produce witherite precipitates from barium chloride and silica solutions that closely resemble primitive organisms.[17] The authors commented on the close resemblance of these crystals to putative nanobacteria, stating that their results showed that evidence for life cannot rest on morphology alone.

See also

References

  1. ^ Kajander E (2006). "Nanobacteria—propagating calcifying nanoparticles". Lett Appl Microbiol. 42 (6): 549–52. doi:10.1111/j.1472-765X.2006.01945.x. PMID 16706890.
  2. ^ Ciftcioglu N, McKay D, Mathew G, Kajander E (2006). "Nanobacteria: fact or fiction? Characteristics, detection, and medical importance of novel self-replicating, calcifying nanoparticles". J Investig Med. 54 (7): 385–94. doi:10.2310/6650.2006.06018. PMID 17169260.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^ a b Miller V, Rodgers G, Charlesworth J, Kirkland B, Severson S, Rasmussen T, Yagubyan M, Rodgers J, Cockerill F, Folk R, Rzewuska-Lech E, Kumar V, Farell-Baril G, Lieske J (2004). "Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves". Am J Physiol Heart Circ Physiol. 287 (3): H1115–24. doi:10.1152/ajpheart.00075.2004. PMID 15142839.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ^ a b Cisar J, Xu D, Thompson J, Swaim W, Hu L, Kopecko D (2000). "An alternative interpretation of nanobacteria-induced biomineralization". Proc Natl Acad Sci USA. 97 (21): 11511–5. Bibcode:2000PNAS...9711511C. doi:10.1073/pnas.97.21.11511. PMC 17231. PMID 11027350.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. ^ a b Martel J, Young JD (2008). "Purported nanobacteria in human blood as calcium carbonate nanoparticles". Proc. Natl. Acad. Sci. U.S.A. 105 (14): 5549–54. Bibcode:2008PNAS..105.5549M. doi:10.1073/pnas.0711744105. PMC 2291092. PMID 18385376. {{cite journal}}: Unknown parameter |month= ignored (help)
  6. ^ Jack Maniloff, quoted in "The Rise and Fall of Nanobacteria", Young and Martel, Scientific American, January 2010
  7. ^ Raoult, D; Drancourt, M; Azza, S; Nappez, C; Guieu, R; Rolain, JM; Fourquet, P; Campagna, B; La Scola, B (2008). "Nanobacteria Are Mineralo Fetuin Complexes". PLoS pathogens. 4 (2): e41. doi:10.1371/journal.ppat.0040041. PMC 2242841. PMID 18282102.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  8. ^ "The Rise and Fall of Nanobacteria", Young and Martel, Scientific American, January 2010
  9. ^ A convention has been adopted between researchers to name -or spell- the nanoparticles isolated from geological specimens as nannobacteria, and those from biological specimens as nanobacteria.
  10. ^ a b Folk, Robert L. (March 4, 1997). "Nanobacteria: surely not figments, but what under heaven are they?". naturalSCIENCE. Retrieved 2008-12-20.
  11. ^ McKay, David S. (1996). "Search for Past Life on Mars: Possible Relic Biogenic Activity in Martian Meteorite ALH84001". Science. 273 (5277): 924–930. Bibcode:1996Sci...273..924M. doi:10.1126/science.273.5277.924. PMID 8688069. {{cite journal}}: Cite has empty unknown parameter: |month= (help); Unknown parameter |coauthors= ignored (|author= suggested) (help)
  12. ^ Kajander E, Ciftçioglu N (1998). "Nanobacteria: An alternative mechanism for pathogenic intra- and extracellular calcification and stone formation". Proc Natl Acad Sci USA. 95 (14): 8274–9. Bibcode:1998PNAS...95.8274K. doi:10.1073/pnas.95.14.8274. PMC 20966. PMID 9653177.
  13. ^ Kumar V, Farell G, Yu S; et al. (2006). "Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles". J. Investig. Med. 54 (7): 412–24. doi:10.2310/6650.2006.06021. PMID 17169263. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  14. ^ Puskás L, Tiszlavicz L, Rázga Z, Torday L, Krenács T, Papp J (2005). "Detection of nanobacteria-like particles in human atherosclerotic plaques". Acta Biol Hung. 56 (3–4): 233–45. doi:10.1556/ABiol.56.2005.3-4.7. PMID 16196199.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  15. ^ Ciftçioglu N, Haddad R, Golden D, Morrison D, McKay D (2005). "A potential cause for kidney stone formation during space flights: enhanced growth of nanobacteria in microgravity". Kidney Int. 67 (2): 483–91. doi:10.1111/j.1523-1755.2005.67105.x. PMID 15673296.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  16. ^ Raoult D, Drancourt M, Azza S; et al. (2008). "Nanobacteria Are Mineralo Fetuin Complexes". PLoS Pathog. 4 (2): e41. doi:10.1371/journal.ppat.0040041. PMC 2242841. PMID 18282102. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
  17. ^ García-Ruiz JM, Melero-García E, Hyde ST (2009). "Morphogenesis of self-assembled nanocrystalline materials of barium carbonate and silica" (PDF). Science. 323 (5912): 362–5. Bibcode:2009Sci...323..362G. doi:10.1126/science.1165349. PMID 19150841. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)

Additional reading